Form S-1/A Sonnet BioTherapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Sonnet BioTherapeutics (SONN) Files for 1.1M Share and Warrant Offering
November 6, 2024 9:25 AM ESTSonnet BioTherapeutics (NASDAQ: SONN) has filed the following:
We are offering 1,103,752 shares of our common stock and common warrants to purchase an aggregate of 2,207,504 shares of our common stock, par value $0.0001 per share (and the shares of common stock that are issuable from time to time upon exercise of the common warrants), at an assumed combined public offering price of $4.53, which is the last reported sale price of our common stock on October 31, 2024. We are also offering to certain purchasers whose purchase of shares of common stock in this offering would otherwise... More
